Atopic mild asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Atopic mild asthmatics and non-atopic non asthmatics 2. Never smokers
Exclusion criteria
Exclusion criteria: 1. Unable to undergo pulmonary function tests 2. Pregnant, possibly pregnant, or nursing 3. Participants who judged that the research directors and researchers were inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is to investigate the regulatory activity of IL-27 in Tr1 cells by evaluating the frequency of IL-27 receptor expression and phosphorylated STAT1/STAT3. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoint is to investigate the correlation between the regulatory activity of IL-27 in Tr1 and the following items (airway hyperresponsiveness, peripheral blood eosinophils, FENO, lung function). | — |
Countries
Japan
Contacts
Kurume University Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University Schoo